Regenerative Medicine Market to register substantial growth by 2024

October 25, 2019


According to the latest study titled ‘Global Regenerative Medicine Market: Analysis By Type (Cell Therapy, Tissue Engineered, Gene Therapy), By Application, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)’ available with Market Study Report LLC, the global regenerative medicine market is estimated to grow substantially by the year 2024.
 

Regenerative medicine helps to fix damaged tissues and organs by enhancing the body’s repair mechanisms. Growing medical research facilities, rising incidences of chronic diseases, increasing investments by pharmaceutical manufacturers towards R&D activities, and favourable government initiatives for improving healthcare infrastructure are the major factors aiding the growth of regenerative medicine market.
 

Additionally, collaborative agreements and growing number of partnerships among the market players will fuel the market growth in the upcoming years. However, high manufacturing cost of these products, coupled with lack of knowledge and awareness about regenerative medicines will restrain regenerative medicine market growth.
 

As per the report, regenerative medicine market was worth US $22814.45 million in 2018 and is presumed to expand momentously over the forecast period. The study examines the market for revenue shares and growth opportunities by different segments. Moreover, it provides an exhaustive understanding about drivers and challenges, alongside trends such as emergence of CAR-T cell therapy and 3-D bioprinting of tissues and organs, influencing the market growth.
 

Based on type, regenerative medicine market is segmented into gene therapy, cell therapy, and tissue engineered. While speaking of application spectrum, the industry is divided into cardiology, orthopaedic & dental, metabolism & inflammation, wound healing, immunology & oncology, and others.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2223375/
 

Considering the geographical landscape, the global regenerative medicine market is fragmented into four major regions as North America, Europe, Asia Pacific, and rest of the world. Whereas, the countries studied are Canada, U.S., Germany, France, Brazil, U.K, Italy, Japan, China, and India.
 

Some of the vendors that operate in regenerative medicine market are Gilead Sciences, Vericel, Spark Therapeutics, Novartis, Orchard Therapeutics, Celgene, MolMed, Amgen, Sanofi, and Shanghai Sunway Biotech.


Frequently Asked Questions (FAQ) :

Growing medical research facilities, rising incidences of chronic diseases, increasing investments by pharmaceutical manufacturers towards R&D activities, and favourable government initiatives for improving healthcare infrastructure are the major factors aiding the growth of regenerative medicine market.
High manufacturing cost, coupled with lack of knowledge and awareness about regenerative medicines will restrain regenerative medicine market growth.
Regenerative medicine market will be impacted by four major regions which are North America, Europe, APAC, and rest of the world, while the impacting countries will be Canada, U.S., Germany, France, Brazil, U.K, Italy, Japan, China, and India.
Major companies of regenerative medicine market are Gilead Sciences, Vericel, Spark Therapeutics, Novartis, Orchard Therapeutics, Celgene, MolMed, Amgen, Sanofi, and Shanghai Sunway Biotech.